KPC PharmaceuticalsInc Balance Sheet Health
Financial Health criteria checks 6/6
KPC PharmaceuticalsInc has a total shareholder equity of CN¥5.6B and total debt of CN¥855.0M, which brings its debt-to-equity ratio to 15.3%. Its total assets and total liabilities are CN¥9.8B and CN¥4.2B respectively. KPC PharmaceuticalsInc's EBIT is CN¥482.3M making its interest coverage ratio 29.4. It has cash and short-term investments of CN¥2.0B.
Key information
15.3%
Debt to equity ratio
CN¥855.01m
Debt
Interest coverage ratio | 29.4x |
Cash | CN¥1.96b |
Equity | CN¥5.59b |
Total liabilities | CN¥4.23b |
Total assets | CN¥9.82b |
Financial Position Analysis
Short Term Liabilities: 600422's short term assets (CN¥7.3B) exceed its short term liabilities (CN¥3.8B).
Long Term Liabilities: 600422's short term assets (CN¥7.3B) exceed its long term liabilities (CN¥429.1M).
Debt to Equity History and Analysis
Debt Level: 600422 has more cash than its total debt.
Reducing Debt: 600422's debt to equity ratio has reduced from 24.1% to 15.3% over the past 5 years.
Debt Coverage: 600422's debt is well covered by operating cash flow (94.9%).
Interest Coverage: 600422's interest payments on its debt are well covered by EBIT (29.4x coverage).